Edgewise Therapeutics (EWTX) Stock: Buy, Sell, or Hold?
EWTX - Edgewise Therapeutics, Inc. Common Stock
$41.40
0.92 (2.27%)
â˛
5d:
+5.24%
30d:
-1.38%
90d:
+3.24%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When EWTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: EWTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: EWTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: EWTX is currently trading at $41.40, which is considered slightly low relative to its 30-day fair value range of $40.95 to $44.84.
Technical Outlook: Technically, EWTX is in a strong uptrend. Immediate support is located at $38.51, while resistance sits at $45.99.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.62 (+27.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EWTX is in a strong uptrend. Immediate support is located at $38.51, while resistance sits at $45.99.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $52.62 (+27.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$40.95 -
$44.84
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.1% below Wall St target ($52.62)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$40.95 -
$44.84
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$38.51
Resistance Level
$45.99
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.80
Wall Street Target
$52.62
(+27.1%)
Share & Embed Analysis
Last updated: October 04, 2026 11:47 AM ET
Data refreshes hourly during market hours. Next update: 12:47 PM
Data refreshes hourly during market hours. Next update: 12:47 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EWTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
23 analysts |
$84 | 71 BUY |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
23 analysts |
$257 | 53 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 73 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$74 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
20 analysts |
$95 | 57 HOLD |
